LAS VEGAS, May 21, 2024--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharmaceuticals, Inc ...

PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 26,800 shares ...

OBIO Orchestra BioMed Holdings, Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...